跳转至内容
Merck
CN
  • Bi-variate approach to negative interference of bilirubin towards an acetaminophen assay.

Bi-variate approach to negative interference of bilirubin towards an acetaminophen assay.

Clinical biochemistry (2014-12-03)
Yeow Kuan Chong, Chloe Miu Mak, Hiu Laam Lam, Man Han Lau, Daniel Cheuk Wa Leung
摘要

It is well known that enzymatic assays for acetaminophen are positively interfered by bilirubin. The effect on acetaminophen not only depends on the concentration of bilirubin but also on that of acetaminophen. We demonstrated a negative interference instead of a positive one in a commonly used routine analyzer and investigated the recovery of acetaminophen in an enzymatic assay by a bi-variate regression. Commercially available blank serum specimens were spiked with acetaminophen and bilirubin at various concentrations, and were analyzed in the Beckman Coulter AU5822 analyzer. The specimens were run in duplicates. The results were then analyzed by least-square analysis and was built into a bi-variate quadratic model. The recovery of acetaminophen in this experiment ranged from 38.9% to 100% throughout a range of 23 μmol/L to 2052 μmol/L (for acetaminophen) and 19 μmol/L to 570 μmol/L (for bilirubin). A contour map, as well as a bi-variate equation was established, describing the relationship between acetaminophen recovery, acetaminophen concentration, and bilirubin concentration. It was shown that the degree of bilirubin interference in a commercially available acetaminophen assay is dependent on both bilirubin and acetaminophen concentrations. There was a decrease in the apparent acetaminophen concentration by an average of 30% at a bilirubin concentration of 420 μmol/L in the Beckman Coulter AU5822 analyzer. The complex relationship can be modeled by mathematical means. This allows the laboratory staff to estimate the recovery of acetaminophen when bilirubin level is concurrently measured.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
对乙酰氨基苯酚, 98%
Supelco
对乙酰氨基酚, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
胆红素, ≥98% (EmM/453 = 60), powder
USP
对乙酰氨基酚, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
对乙酰氨基酚, BioXtra, ≥99.0%
Sigma-Aldrich
对乙酰氨基酚, meets USP testing specifications, 98.0-102.0%, powder
Sigma-Aldrich
对乙酰氨基酚, analytical standard
扑热息痛, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
胆红素, purum, ≥95.0% (UV)
Supelco
醋氨酚 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®